> Detailanzeige

Kang, EunKyo; Kang, Jung Hun; Koh, Su-Jin; Song, Eun-Kee; Shim, Hyun-Jeong; Keam, Bhumsuk; Maeng, Chi-Hoon; Kim, Yu Jung; Yun, Hwan Jung; Jung, Kyung Hae; Kwon, Jung Hye; Lee, Soon Nam; Lee, Jung Lim; Do, Young Rok; Min, JeongHee; Lee, Jihye; Choo, Jiyeon; Yun, Young Ho

The Impacts of Prognostic Awareness on Mood and Quality of Life Among Patients With Advanced Cancer

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: The Impacts of Prognostic Awareness on Mood and Quality of Life Among Patients With Advanced Cancer
  • Beteiligte: Kang, EunKyo; Kang, Jung Hun; Koh, Su-Jin; Song, Eun-Kee; Shim, Hyun-Jeong; Keam, Bhumsuk; Maeng, Chi-Hoon; Kim, Yu Jung; Yun, Hwan Jung; Jung, Kyung Hae; Kwon, Jung Hye; Lee, Soon Nam; Lee, Jung Lim; Do, Young Rok; Min, JeongHee; Lee, Jihye; Choo, Jiyeon; Yun, Young Ho
  • Erschienen: SAGE Publications, 2020
  • Erschienen in: American Journal of Hospice and Palliative Medicine®
  • Sprache: Englisch
  • DOI: 10.1177/1049909120905789
  • ISSN: 1938-2715; 1049-9091
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec><jats:title>Background:</jats:title><jats:p> Accurate awareness of the prognosis is an important factor in the treatment decision of patients with advanced cancer; however, prognostic disclosure is still subject to debate because it can reduce patient’s satisfaction and increase depression. </jats:p></jats:sec><jats:sec><jats:title>Aim:</jats:title><jats:p> The purpose of this study is to assess whether patients’ prognostic awareness is associated with decreased quality of life (QoL) or increased depressive mood in patients with advanced cancer </jats:p></jats:sec><jats:sec><jats:title>Design and Participants:</jats:title><jats:p> In this cohort study, 386 patients with advanced cancer were recruited across 3 periods from December 2016 to August 2018. The outcome of this study was a change in QoL and depression according to the patients’ prognostic awareness at baseline, 3 months, and 6 months. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> This study found significant differences in changes of QoL based on patients’ prognostic awareness. From baseline to 3 months, emotional functioning ( P = .039), pain ( P = .042), existential well-being ( P = .025), and social support ( P = .038) subscale scores improved significantly more in those with lack of prognostic awareness. Over 6 months, the group without prognostic awareness improved significantly in terms of physical functioning ( P = .037), emotional functioning ( P = .002), nausea/vomiting ( P = .048), and constipation ( P = .039) subscale scores and existential well-being scores ( P = .025). No significant difference between the groups was found in terms of depression. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> Accurate prognostic awareness may pose harm and may provide no additional benefits in terms of QoL and mood among patients with advanced cancer for a short period of time. </jats:p></jats:sec>